pKVL2-U6gRNA_SAM(BbsI)-PGKpuroBFP-W Citations (4)
Originally described in: Pooled extracellular receptor-ligand interaction screening using CRISPR activation.Chong ZS, Ohnishi S, Yusa K, Wright GJ Genome Biol. 2018 Nov 26;19(1):205. doi: 10.1186/s13059-018-1581-3. PubMed Journal
Articles Citing pKVL2-U6gRNA_SAM(BbsI)-PGKpuroBFP-W
| Articles |
|---|
Pooled extracellular receptor-ligand interaction screening using CRISPR activation.
Chong ZS, Ohnishi S, Yusa K, Wright GJ.
Genome Biol. 2018 Nov 26;19(1):205. doi: 10.1186/s13059-018-1581-3.
PubMed
Associated Plasmids |
| A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity. Lee DH, Ahn H, Sim HI, Choi E, Choi S, Jo Y, Yun B, Song HK, Oh SJ, Denda-Nagai K, Park CS, Irimura T, Park Y, Jin HS. J Exp Clin Cancer Res. 2023 Oct 20;42(1):272. doi: 10.1186/s13046-023-02840-9. PubMed |
Uncovering receptor-ligand interactions using a high-avidity CRISPR activation screening platform.
Yang L, Sheets TP, Feng Y, Yu G, Bajgain P, Hsu KS, So D, Seaman S, Lee J, Lin L, Evans CN, Guest MR, Chari R, St Croix B.
Sci Adv. 2024 Feb 16;10(7):eadj2445. doi: 10.1126/sciadv.adj2445. Epub 2024 Feb 14.
PubMed
Associated Plasmids |
| Cell softness renders cytotoxic T lymphocytes and T leukemic cells resistant to perforin-mediated killing. Zhou Y, Wang D, Zhou L, Zhou N, Wang Z, Chen J, Pang R, Fu H, Huang Q, Dong F, Cheng H, Zhang H, Tang K, Ma J, Lv J, Cheng T, Fiskesund R, Zhang X, Huang B. Nat Commun. 2024 Feb 15;15(1):1405. doi: 10.1038/s41467-024-45750-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.